PubMed · 9575721
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
D Das, T Antalki, J D Talley. 1998. Tuberculous pericarditis?. https://pubmed.ncbi.nlm.nih.gov/9575721/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Becton Dickinson Biosciences (Sparks, Maryland) has issued a voluntary recall of a lot of isoniazid [INH] (drug lot no. 9335260) used for antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis. The recalled INH lot was sold as components of BACTEC S.I.R.E. kits (lot nos. 9327296, 9342298, and 9327298) and as individual drug for reconstitution (BACTEC Isoniazid kit lot no. 9327297) during January 2000-August 25, 2000.
Globally the proportion of tuberculosis cases caused by drug-resistant strains is increasing. Interruptions in the drug supply, improper drug prescription and nonadherence to treatment protocols promote drug resistance through mechanisms that are now well understood. The treatment of tuberculosis must take into account the possibility of drug resistance and include at least 2 drugs, preferably 3, to which the isolate is proven or anticipated to be susceptible.
Explore the source record for details and available documents.